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Abstract 
Phytoestrogens are estrogenic compounds that occur naturally in plants. Phytoestrogens can 
cross the placenta, and animal studies have found associations between in utero exposure to 
phytoestrogens and markers of early puberty. We investigated the association between in utero 
exposure to phytoestrogens and early menarche (defined as <11.5 years of age at onset) using 
data from a nested case-control study within the Avon Longitudinal Study of Parents and 
Children, a longitudinal study involving families living in the South West of England. 
Concentrations of six phytoestrogens were measured in maternal urine samples collected during 
pregnancy. Logistic regression was used to explore associations between tertiles of 
phytoestrogen concentrations and menarche status, with adjustment for maternal age at 
menarche, maternal education, pre-pregnancy body mass index (BMI), child birth order, and 
duration of breastfeeding. Among 367 mother-daughter dyads, maternal median (interquartile 
range) creatinine-corrected concentrations (in µg/g creatinine) were: daidzein 184.8 (88.8–
383.7), enterodiol 76.1 (39.1–135.8), enterolactone 911.7 (448.1–1558.0), equol 4.3 (2.8–9.0), 
genistein 62.1 (27.1–160.9), and O-desmethylangolensin (O-DMA) 13.0 (4.4–34.5). In analyses 
comparing those in the highest tertile relative to those in the lowest tertile of in utero 
phytoestrogen exposure, higher enterodiol levels were inversely associated with early menarche 
(OR=0.45; 95% CI: 0.25–0.81), while higher O-DMA levels were associated with early 
menarche (odds ratio (OR) = 1.94; 95% confidence interval (CI): 1.07–3.51). These findings 
suggest that in utero exposure to phytoestrogens may be associated with earlier age at menarche, 
though the direction of association differs across phytoestrogens. 
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1. Introduction 
Puberty is a crucial period of growth and development. The timing and patterning of 
pubertal events, such as age at menarche, can provide information on overall health and some 
previous exposures, while potentially forecasting future health outcomes (Christensen et al, 
2011; Biro et al, 2001; Golub et al, 2008).  
Age at menarche, on average, has decreased since the late 19th century (Wyshak & 
Frisch, 1982; Zacharias & Wurtman, 1969), and a secular trend towards earlier development of 
secondary sexual characteristics has been reported among girls in the Avon Longitudinal Study 
of Parents and Children (ALSPAC) based in the United Kingdom (Rubin et al, 2009). In the 
United States, recent estimates for average age at menarche (12.4 years) are almost a year 
younger than the average age at menarche of women born in the 1920s (13.3 years), and 
decreases in average age at menarche have been observed across all racial/ethnic groups 
(McDowell et al, 2007). While improvements in nutritional status since the 19th century and the 
increasing prevalence of childhood obesity may be in part responsible for this trend, exposure to 
endocrine disrupting chemicals (EDCs) may also lead to altered timing and patterning of 
pubertal development (Herman-Giddens et al, 1997; Buck Louis et al, 2008; Blanck et al, 2000; 
Biro et al, 2012; Christensen et al, 2011). 
EDCs are chemicals that may affect the body’s endocrine system and cause adverse 
developmental, reproductive, neurological, and immune effects in humans and animals. EDCs 
can be natural or man-made, and research suggests that EDCs may have the greatest impact 
during prenatal and early postnatal development when organ and neural systems are forming 
(National Institute of Environmental Health Sciences, 2015). Most EDCs have estrogenic and/or 
anti-androgenic actions (Daxenberger et al, 2001), which are thought to have puberty-inducing 
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effects in females (Mouritsen et al, 2010). Previous studies have examined the associations of in 
utero exposure to various EDCs with pubertal development, particularly age at menarche, with 
some conflicting results (Vasiliu et al, 2004; Blanck et al, 2000; Hatch et al, 2011; Christensen et 
al, 2011). Most studies were limited by the use of retrospectively-collected age at menarche data.  
One potential class of naturally-occurring EDCs of interest is phytoestrogens. 
Phytoestrogens are estrogenic compounds that occur naturally in plants, with the most common 
dietary source of phytoestrogens being soybean products (Kim & Park, 2012). Although 
exposure to phytoestrogens is mostly dietary, phytoestrogens can cross the placental barrier in 
humans (Foster et al, 2002). Phytoestrogen exposure may affect sexual development, including 
altered pubertal timing (Kim & Park, 2012).  
Animal studies have reported the effects of phytoestrogens to be quite different according 
to time, dosage and route. Studies in rodents found that exposure to high doses of phytoestrogens 
(isoflavones) in utero and through diet in early life accelerated pubertal onset in female animals 
(Casanova et al, 1999; Takashima-Sasaki et al, 2006). In humans, the effect of soy-based infant 
formula on pubertal development has been studied to some extent, though this has yielded mixed 
results regarding an association with age at menarche (Adgent et al, 2011; Strom et al, 2001). 
However, there have been no human studies published to date that have investigated the 
association between in utero phytoestrogen exposure and age at menarche. Our aim was to do so, 
using maternal gestational levels of phytoestrogen exposure and prospectively-collected age at 
menarche data in a population-based nested case-control study.  
2. Study design and methods 
2.1 Study population 
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 The Avon Longitudinal Study of Parents and Children (ALSPAC) is an ongoing 
prospective birth cohort of 14,541 pregnancies. ALSPAC enrolled pregnant women with an 
expected delivery date between April 1st, 1991 and December 31st, 1992 from three health 
districts in the former county of Avon, Great Britain. Information has been collected on these 
parents and children through interviews, mailed questionnaires, and clinic visits. Details on 
ALSPAC recruitment and study methods have been described elsewhere (Boyd et al, 2013).  
 A nested case-control study was conducted within the ALSPAC cohort to explore 
associations of prenatal maternal concentrations of various EDCs and age at menarche among 
the daughters. A ‘Growing and Changing’ questionnaire was developed to collect information on 
the offspring’s pubertal development and distributed to participants annually between the ages of 
8–17 years (1999–2008), with the exception of age 12 (2003). Menarche was determined through 
parental- or self-report of menarche status, and, if it had occurred, month and year of occurrence 
so that age could be computed. From the original base population of 14,062 live births, case and 
control series were selected from singleton (n=11,820) female subjects (n=5,756) who had 
completed at least two puberty staging questionnaires between the ages of 8 and 13 (5 possible 
questionnaires returned; n=3,682). Girls meeting eligibility criteria were ordered according to 
reported age at menarche when the 13-year old data became available. A cut-off of 11.5 years 
was established as defining ‘early’ menarche to satisfy sample size and power needed for the 
case-control study. Eligible cases could complete any two questionnaires in the series, provided 
that one was completed after menarche, while controls had to complete the 13-year old 
questionnaire in order to ascertain that menarche had not occurred by the cut-off of 11.5 years. 
Of the girls who reported menarche before the age of 11.5 (n=338), 59.8% (n=202) had a 
prenatal maternal urine sample available, and were considered potential cases. Among girls who 
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reported menarche at or after the age of 11.5, a random sample of 394 was chosen as potential 
controls, and of these, 61.2% (n=241) had a maternal urine sample available. After evaluating the 
integrity of the maternal urine samples, 86.1% (n=174) of potential case and 81.3% (n=196) of 
potential control samples were analyzed. Two cases and one control were excluded due to 
missing creatinine concentrations, leaving a total sample size of 367 mother-daughter dyads. 
2.2 Laboratory analysis 
Maternal urine samples were stored at -20 degrees Celsius before being transferred under 
controlled conditions to the National Center for Environmental Health, Centers for Disease 
Control and Prevention (Atlanta, GA) for analysis using high-performance liquid 
chromatography–tandem mass spectrometry. The analytical methods are described elsewhere 
(Rybak et al, 2008). Phytoestrogens (enterolactone, daidzein, genistein, enterodiol, O-
desmethylangolensin, and equol) were measured in maternal first morning void urine samples 
collected at a median gestational age of 12 weeks (interquartile range 8–17 weeks). 
Phytoestrogen concentrations were creatinine-corrected (CDC, 2012). Maternal urine 
concentrations were used as a proxy for fetal exposure (Green & Marsit, 2015; Ahmed et al, 
2011). 
2.3 Statistical analysis 
 Potential confounders to be considered in the analyses were identified a priori based on 
previously published literature and biological plausibility. Covariates were collected at various 
time points. We considered the following as covariates: child race (white/non-white); maternal 
education (ordinally classified as <O-level (ordinary level: required, completed at age 16), O-
level, or >O-level); maternal age at menarche (8–11 years / 12–15 years); maternal pre-
pregnancy self-reported body mass index (BMI) (kg/m2); prenatal vegetarian diet (yes/no); 
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prenatal smoking (any/none); maternal age at delivery (years); child birth order (first born, 
second born, or third born or later); child birth weight (<2500 g / ≥2500 g); breastfeeding 
duration (ordinally classified as not breastfed, <3 months, 3–5 months, ≥6 months); use of infant 
soy formula (any/none); vegetarian diet during childhood (yes/no); and objectively measured 
childhood BMI Z-score at age 8 (if missing for age 8, used age 7, 9, or 10). 
All data analysis was performed using SAS 9.3 (Cary, NC). Descriptive statistics were 
calculated for the sample comprised of 367 mother-daughter dyads; chi square and Fisher’s exact 
tests were used to compare groups by menarche status. Medians and interquartile ranges were 
calculated for each phytoestrogen for the total sample and by menarche status, and the Wilcoxon 
rank sum test was used to compare groups by menarche status.  
Prior to modeling, phytoestrogen concentrations were log transformed. Phytoestrogen 
concentrations were also divided into tertiles by using cut points based on the distribution among 
the controls. To investigate the association between maternal phytoestrogen concentration and 
earlier age at menarche, unconditional logistic regression models were used. Using the set of 
potential confounding variables selected a priori for consideration in multivariable regression 
models, the final model was achieved through hierarchical backwards elimination of 
insignificant variables (Kleinbaum et al, 1982). Maternal education, maternal age at menarche, 
maternal vegetarian diet, and childhood BMI were considered as potential effect modifiers. 
Given that 15% (n=56) of observations were missing data for covariates included in the model, 
multiple imputation using the fully conditional specification method was performed to address 
missing covariate data (Liu & De, 2015).  
Please note that the ALSPAC study website contains details of all the data that are 
available through a fully searchable data dictionary: http://www.bristol.ac.uk/ 
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alspac/researchers/access/ (University of Bristol, 2015). Ethical approval for the study was 
obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics 
Committees. The U.S. Centers for Disease Control and Prevention (CDC) Institutional Review 
Board assessed and approved human subjects protection. Mothers provided informed consent at 
time of enrollment. 
3. Results 
In the ALSPAC cohort, girls were predominantly born to white mothers, most of whom 
had ordinary levels of education or higher (Table 1). Cases were more likely to have mothers 
who had an earlier age at menarche; one-third of case mothers reported menarche between 8 and 
11 years of age, compared to less than 14% of control mothers. Mothers of cases were more than 
twice as likely to have an overweight or obese pre-pregnancy BMI, and cases were more than 
twice as likely to have a childhood BMI that was more than one standard deviation above the 
mean. Cases were more likely to be the first born child (61.6% versus 51.6%) and more likely to 
have never been breastfed or breastfed for less than 3 months (48.5% versus 39.9%). The median 
age of menarche among cases was 11.0 years, while the median age of menarche among controls 
was almost two years later at 12.8 years.  
Table 1. Characteristics of the Avon Longitudinal Study of Parents and Children (ALSPAC) 
nested case-control study population (N=367 mother-daughter dyads). 
 Menarche  
<11.5 years  
(N=172) 
Menarche  
≥11.5 years      
(N=195) 
P-value for 
differencea 
Characteristic N % N %  
Child race 
    White 
    Non-white 
Maternal educationc 
    < O-level 
    O-level 
    >O-level 
Maternal age at menarche, years 
    8–11 
 
159 
7 
 
36 
56 
74 
 
50 
 
95.8 
4.2 
 
21.7 
33.7 
44.6 
 
33.3 
 
182 
6 
 
32 
62 
97 
 
23 
 
96.8 
3.2 
 
16.8 
32.5 
50.8 
 
13.9 
0.61 
 
 
0.39 
 
 
 
<0.0001 
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    ≥12 
Maternal pre-pregnancy BMI, kg/m2 
    <25 (under/normal weight) 
    ≥25 (overweight/obese) 
Prenatal vegetarian diet 
    Yes 
    No 
Prenatal smoking 
    Any 
    None 
Maternal age at delivery, years 
    <25 
    25–29  
    ≥30  
Child birth order 
    First born 
    Second born 
    Third born or later 
Child birth weight, g d 
    <2500 
    ≥2500 
Breastfeeding duration, months 
    Not breastfed 
    <3  
    3–5  
    ≥6 
Use of infant soy formula d 
    Any 
    None 
Vegetarian diet during childhood 
    Yes 
    No 
Childhood BMI Z-score 
    <0 
    0–1 
    ≥1 
Age at menarche, years 
100 
 
113 
43 
 
10 
154 
 
29 
139 
 
32 
71 
68 
 
101 
36 
27 
 
<5 
166 
 
26 
53 
26 
58 
 
<5 
163 
 
8 
158 
 
32 
50 
71 
Median 
66.7 
 
72.4 
27.6 
 
6.1 
93.9 
 
17.3 
82.7 
 
18.7 
41.5 
39.8 
 
61.6 
22.0 
16.5 
 
-- 
-- 
 
16.0 
32.5 
16.0 
35.6 
 
-- 
-- 
 
4.8 
95.2 
 
20.9 
32.7 
46.4 
IQR 
142 
 
159 
22 
 
11 
177 
 
27 
160 
 
35 
73 
87 
 
97 
66 
25 
 
<5 
188 
 
38 
35 
34 
76 
 
<5 
187 
 
7 
176 
 
60 
77 
37 
Median 
86.1 
 
87.8 
12.2 
 
5.9 
94.1 
 
14.4 
85.6 
 
17.9 
37.4 
44.6 
 
51.6 
35.1 
13.3 
 
-- 
-- 
 
20.8 
19.1 
18.6 
41.5 
 
-- 
-- 
 
3.8 
96.2 
 
34.5 
44.3 
21.3 
IQR 
 
0.0004 
 
 
0.92 
 
 
0.47 
 
 
0.63 
 
 
 
0.03 
 
 
 
1.00b 
 
 
0.04 
 
 
 
 
0.43b 
 
 
0.65 
 
 
<0.0001 
    11.0 10.7-11.3 12.8 12.3-13.4  
Abbreviations: g, grams; kg/m2, kilograms per meter-squared; IQR, interquartile range 
a Compared using chi-square tests unless otherwise noted 
b Compared using Fisher’s exact test 
c <O-level=none, Certificate of Secondary Education, and vocational education, which are equivalent to 
no diploma or a GED in the United States. O-levels (ordinary levels) are required and completed at the 
age of 16. >O-level=A-levels (advanced levels) completed at 18, which are optional, but required to get 
into university; and a university degree. 
d Counts and percents suppressed due to small cell sizes 
Median enterodiol concentrations were almost 15 µg/g creatinine lower among cases than 
among controls, while median O-desmethylangolensin (O-DMA) concentrations were more than 
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2 µg/g creatinine higher among cases than among controls (Table 2). There were no other 
differences evident.  
Table 2. Gestational urinary phytoestrogen concentrations among mothers of girls with and 
without earlier age at menarche in the Avon Longitudinal Study of Parents and Children 
(ALSPAC) nested case-control study population (N=367 mother-daughter dyads). 
 Total Menarche <11.5 years 
(N=172) 
Menarche ≥11.5 years 
(N=195) 
p-
valueb 
Analytea Median IQR Median IQR Median IQR 
 
Enterolactone 
Daidzein 
Genistein 
Enterodiol 
O-DMA 
Equol 
911.7 
184.8 
62.1 
76.1 
13.0 
4.3 
448.1–1558.0 
88.8–383.7 
27.1–160.9 
39.1–135.8 
4.4–34.5 
2.8–9.0 
901.1 
187.8 
60.2 
69.6 
14.0 
4.4 
494.8–1478.2 
91.9–369.7 
26.6–157.6 
33.6–123.6 
5.7–43.8 
2.8–7.4 
923.8 
183.0 
65.1 
84.3 
11.7 
4.2 
440.6–1650.9 
88.8–423.8 
27.2–162.7 
49.4–144.4 
3.4–31.5 
2.6–9.6 
0.89 
0.79 
0.58 
0.02 
0.06 
0.74 
Abbreviations: IQR, interquartile range; O-DMA, O-Desmethylangolensin 
a Creatinine-corrected concentrations in µg/g creatinine 
b p-value for difference between cases and controls using the Wilcoxon Rank Sum Test 
c There are missing concentrations for genistein (n=1 where menarche <11.5 years), O-DMA (n=2 where 
menarche <11.5 years), and equol (n=1 where menarche <11.5 years and n=1 where menarche ≥11.5 
years) 
In the unadjusted model, decreased odds of early menarche were observed for those in 
the second and third tertiles of in utero enterodiol exposure compared to those in the lowest 
tertile (odds ratio (OR)second=0.60; 95% confidence interval (CI)second: 0.36–0.98; p-
valuesecond=0.04; ORthird=0.58; 95% CIthird: 0.35–0.96; p-valuethird=0.03; p-trend: 0.03) (Table 3). 
Increased odds of early menarche were observed for those in the second and third tertiles of in 
utero O-DMA exposure compared to those in the lowest tertile (ORsecond=1.91; 95% CIsecond: 
1.12–3.27; p-valuesecond: 0.02; ORthird=1.97; 95% CIthird: 1.16–3.35; p-valuethird: 0.02; p-trend: 
0.02).  
The results of the analyses adjusting for maternal age at menarche, maternal education, 
pre-pregnancy BMI, child birth order, and duration of breastfeeding were similar to those from 
the unadjusted analyses (Table 3). In the adjusted model, the odds of early menarche for each 
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unit increase of logged mothers’ enterodiol concentration were OR=0.75 (95% CI: 0.59–0.96; p-
trend: 0.02). When enterodiol was treated categorically, decreased odds of early menarche were 
observed for those in the second and third tertiles of in utero enterodiol exposure compared to 
those in the lowest tertile (ORsecond=0.44; 95% CIsecond: 0.25–0.77; p-valuesecond=0.005; 
ORthird=0.45; 95% CIthird: 0.25–0.81; p-valuethird=0.008; p-trend: 0.007). The odds of early 
menarche for each unit increase of logged mothers’ O-DMA concentration were OR=1.14 (95% 
CI: 1.00–1.29; p-trend: 0.05). When comparing those in the third tertile of O-DMA concentration 
to those in the lowest tertile, a 94% increase in the odds of early menarche was observed 
(ORthird=1.94; 95% CIthird: 1.07–3.51; p-valuethird=0.03; p-trend: 0.03). No other significant 
associations were observed between phytoestrogen concentration and early menarche. There was 
no evidence of effect modification by maternal education, maternal age at menarche, maternal 
vegetarian diet, or childhood BMI. 
Table 3. Associations of maternal urinary phytoestrogen concentrations with earlier age at 
menarche in the Avon Longitudinal Study of Parents and Children (ALSPAC) nested case-
control study population (N=367 mother-daughter dyads). 
  Unadjusteda  Adjustedab 
       
Analytec OR (95% CI) p 
valuef 
p for 
trendf 
OR (95% CI) p 
valuef 
p for 
trendf 
Enterolactone 
  Continuousd 
  Tertile 2e (551.49–1314.96) 
  Tertile 3e  (1314.96–8718.04) 
Daidzein 
  Continuous 
  Tertile 2 (110.09–319.03) 
  Tertile 3 (319.03–21880.45) 
Genistein 
  Continuous 
  Tertile 2 (38.86–118.38) 
  Tertile 3 (118.38–17916.60) 
Enterodiol 
  Continuous 
  Tertile 2 (56.49–117.99) 
 
1.04 (0.87–1.26) 
1.39 (0.85–2.28) 
0.98 (0.58–1.65) 
 
1.03 (0.87–1.22) 
1.37 (0.83–2.25) 
1.00 (0.59–1.68) 
 
0.96 (0.83–1.11) 
1.02 (0.62–1.67) 
0.87 (0.52–1.44) 
 
0.79 (0.64–0.98) 
0.60 (0.36–0.98) 
 
 
0.19 
0.93 
 
 
0.21 
0.99 
 
 
0.94 
0.58 
 
 
0.04 
 
0.65 
 
0.94 
 
0.70 
 
0.99 
 
0.55 
 
0.59 
 
0.03 
 
 
1.23 (0.98–1.55) 
1.78 (1.02–3.10) 
1.65 (0.90–3.02) 
 
1.02 (0.84–1.24) 
1.14 (0.66–1.99) 
0.85 (0.47–1.51) 
 
0.92 (0.78–1.08) 
0.90 (0.52–1.56) 
0.76 (0.43–1.35) 
 
0.75 (0.59–0.96) 
0.44 (0.25–0.77) 
 
 
0.04 
0.10 
 
 
0.64 
0.57 
 
 
0.70 
0.35 
 
 
0.005 
 
0.07 
 
0.10 
 
0.83 
 
0.58 
 
0.30 
 
0.31 
 
0.02 
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  Tertile 3 (117.99–1188.20) 
O-DMA 
  Continuous 
  Tertile 2 (4.77–21.04) 
  Tertile 3 (21.04–1631.58) 
Equol 
  Continuous 
  Tertile 2 (3.19–6.93) 
  Tertile 3 (6.93–9005.85) 
0.58 (0.35–0.96) 
 
1.12 (1.00–1.26) 
1.91 (1.12–3.27) 
1.97 (1.16–3.35) 
 
0.97 (0.83–1.13) 
1.22 (0.74–1.99) 
0.86 (0.51–1.44) 
0.03 
 
 
0.02 
0.02 
 
 
0.44 
0.55 
0.03 
 
0.05 
 
0.02 
 
0.70 
 
0.57 
0.45 (0.25–0.81) 
 
1.14 (1.00–1.29) 
1.54 (0.85–2.77) 
1.94 (1.07–3.51) 
 
0.98 (0.82–1.15) 
1.10 (0.63–1.91) 
0.90 (0.51–1.60) 
0.008 
 
 
0.15 
0.03 
 
 
0.74 
0.72 
0.007 
 
0.05 
 
0.03 
 
0.78 
 
0.73 
a Unconditional logistic regression 
b Adjusted for maternal age at menarche, maternal education, pre-pregnancy BMI, child birth order, and 
duration of breastfeeding 
c Creatinine-corrected concentrations in µg/g creatinine  
d Continuous represents natural log transformed values of phytoestrogen concentration 
e Tertiles represent the comparison of the higher tertiles, tertiles 2 or 3, to the lowest tertile of 
phytoestrogen concentration 
f The p-value is for the comparison of tertile 2 or 3 to the lowest tertile of phytoestrogen concentration; 
the p for trend is for the trend across all three tertiles 
 
4. Discussion 
In this study, we observed strong associations between enterodiol and decreased odds of 
earlier age at menarche, and some evidence of an association between O-DMA and increased 
odds of earlier age at menarche.  
Studies have suggested that lignans such as enterodiol and enterolactone exhibit biphasic 
effects (estrogenic and antiestrogenic effects), which are dependent on exposure level (Tang et 
al, 2015; Mousavi and Adlercreutz, 1992; Mueller et al, 2004; Pettersson and Gustafsson, 2001; 
Waters and Knowler, 1982; Welshons et al, 1987; Adlercreutz, 2007; Wang, 2002). At relatively 
low doses, some lignan exposures demonstrate estrogenic activity, stimulating cell growth, while 
at higher doses appear to behave as antiestrogenic agents, suppressing cell growth (Wang, 2002). 
The biphasic effects of lignans could potentially provide an explanation for the negative 
association observed between enterodiol and early menarche status.  
O-DMA is an intestinal bacterial metabolite of daidzein, and about 90% of individuals 
harbor bacteria capable of metabolizing daidzein to O-DMA (Frankenfield, 2011). O-DMA is 
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less structurally similar to 17β-estradiol than its parent compound and therefore may exhibit 
different biological actions than daidzein. The underlying bacteria that metabolize daidzein to O-
DMA may have a distinct physiological role; urinary excretion of O-DMA is a marker of 
harboring intestinal bacteria capable of C-ring cleavage, and therefore it is suspected that the role 
of the phenotype may extend beyond daidzein metabolism (Frankenfield, 2011). 
To our knowledge, this is the first published study of associations of in utero 
phytoestrogen exposure with age at menarche. Although there were few significant associations 
found between phytoestrogen levels and age at menarche, there is biological plausibility for such 
an association. Exposures during pregnancy are extremely relevant to pubertal development, 
since this represents the period of initial organ development, including the brain, endocrine 
system, and reproductive tract. Furthermore, the fetus is more susceptible to such exposures due 
to smaller size, lack of a complete blood-brain barrier, and absence of metabolizing enzymes 
(Todaka et al, 2005). Studies have found that phytoestrogens can cross the placental barrier in 
humans, and one study (n=53) of Californian women undergoing amniocentesis found that 96% 
of second trimester amniotic fluid samples contained quantifiable amounts of dietary 
phytoestrogens (Foster et al, 2002). Based on evidence from animal studies, the main mechanism 
of action of phytoestrogens—the binding of phytoestrogens to estrogen receptors—may be 
particularly relevant for in utero exposure to phytoestrogens because of the timing of 
differentiation and development (Takagi et al, 2004; Takashima-Sasaki et al, 2006; Casanova et 
al, 1999). Studies in rodents have found that isoflavones administered through diet or 
subcutaneous injection during gestation or early life can lead to early vaginal opening (akin to 
early menarche in humans), irregular estrous cyclicity, and decreased GnRH activation (GnRH 
coordinates reproductive maturation and function) (Takagi et al, 2004; Takashima-Sasaki et al, 
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2006; Casanova et al, 1999; Kouki et al, 2003; Lewis et al, 2003; Bateman & Patisaul, 2008; Lee 
et al, 2009; Nagao et al, 2001).  
To our knowledge, no previous studies have investigated in utero phytoestrogen 
exposure; therefore, we looked to previous studies on the effect of in utero exposure to other 
potential EDCs, which produced mixed results, as have previous studies on early life 
phytoestrogen exposure to soy infant formula. A cohort study (n=151) assessing in utero 
exposure to polychlorinated biphenyls (PCBs) and dichlorodiphenyldichloroethlene (DDE) with 
age at menarche found that increased exposure to DDE was associated with an earlier age at 
menarche, while exposure to PCBs was not associated (Vasiliu et al, 2004). A nested case-
control study (n=448) found no association with in utero exposure to polyfluoroalkyl chemicals 
(PFCs) and age at menarche (Christensen et al, 2011). Studies on the association between soy-
based infant formula and age at menarche are also inconclusive (the phytoestrogens found in soy 
are daidzein and genistein; O-DMA and equol are metabolites of daidzein). A retrospective 
cohort study (n=811) found no association between soy-based formula and self-reported recalled 
age at menarche (Strom et al, 2001). However, a prospective cohort study (n=2,028) in British 
girls of the ALSPAC study found a 53% increased risk of early menarche among those fed soy-
based formula, when compared to cows’ milk-based formula (Adgent et al, 2011); it should be 
noted that this paper examined the ALSPAC cohort as a whole, as opposed to the nested case-
control study used in this paper. While it is difficult to compare across classes of EDCs and at 
different times of exposure, previous studies have yet to suggest a clear association between in 
utero and early life exposure to EDCs and age at menarche. 
Strengths of this study are the inclusion of multiple phytoestrogen biomarkers, substantial 
covariate data available on mothers and children from multiple time points over gestation and 
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childhood, and outcome data generally collected in the year that the outcome occurred. 
Limitations of this study include a single spot urine measurement of phytoestrogen exposure 
which was not collected at a uniform time of gestation, the absence of a ‘Growing and Changing’ 
questionnaire at age 12, missing information on age at menarche among some controls, 
incomplete information on some covariates, and no assessment of phytoestrogen exposure or 
early childhood soy consumption (excluding soy formula) in the daughters, which might 
influence timing of menarche. Unlike some other EDCs that are estimated to have half-lives on 
the order of several years, peak rates of urinary excretion of phytoestrogens occur between 6 and 
12 hours after ingestion (King & Bursill, 1998). Since phytoestrogens are excreted rather 
quickly, phytoestrogen exposure assessed through urinary excretion at a single time point may 
under- or overestimate intermittent phytoestrogen exposure. Age at menarche was obtained 
through self-report on ‘Growing and Changing’ puberty questionnaires completed every year by 
parents and/or children, depending on age. There is some potential for misclassification of the 
outcome, such as the completion of the questionnaire by a parent unaware of the child’s 
menarche status, or issues in the parent or child’s recall of the month and year menstruation 
began.  
Urinary phytoestrogen concentrations during 1991–1992 among mothers of girls 
participating in the ALSPAC cohort were roughly two to three times higher for all 
phytoestrogens except equol (which was half as high) when compared to 2003–2006 National 
Health and Nutrition Examination Survey (NHANES) data for white women between 20 and 39 
years old (CDC, 2012) (data not shown). It should be noted though that these samples were taken 
more than a decade apart. 
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It is also possible that the girls selected for this nested case-control study were not 
representative of the base cohort. When comparing ALSPAC girls who returned at least two 
‘Growing and Changing’ questionnaires to those who did not return any questionnaires, non-
respondents’ parents were more likely to have lower educational attainment. Compared to non-
respondents, mothers of respondents were generally older at time of index birth. Further, non-
respondents were more likely to be of non-white race. This could have affected our findings 
since socioeconomic status is related to age at menarche (Braithwaite et al, 2009); however, 
whether socioeconomic status is related to phytoestrogen concentrations is unclear. Although 
race is related to age at menarche (Biro et al, 2006; Biro et al, 2001; Wu et al, 2002; Freedman et 
al, 2002; Britton et al, 2004; McDowell et al, 2007) and was associated with maternal lignan 
concentrations in this study, we were not able to examine the effect of race due to the small 
number of non-white girls enrolled in ALSPAC. Furthermore, it has been suggested that several 
genes in Caucasians code for early menarche (Dvornyk and Waqar-ul-Haq, 2012), and since we 
did not include genetic data in this study, we do not know if our results could be affected. Last, 
due to a modest sample size, this study may have been underpowered to detect additional 
associations between in utero phytoestrogen exposure and age at menarche.  
5. Conclusions 
In summary, we compared exposure to phytoestrogens during pregnancy among mothers 
of girls who did and did not have earlier age at menarche in the ALSPAC cohort. We found an 
association between O-DMA and increased odds of earlier age at menarche, while decreased 
odds of earlier age at menarche were observed for enterodiol. As demonstrated in our study by 
the conflicting effects of phytoestrogens, plus the general lack of human studies on the 
associations between phytoestrogens and pubertal outcomes, there is a need for additional studies 
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to explore these associations in a variety of populations and to describe potential mechanisms of 
action for O-DMA and enterodiol.  
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